Evidence map›Paper›PMID 41031483›Full record

ArticleGenomics, proteomics & bioinformatics2026

Spatial Transcriptomics of Human Decidua Identifies Molecular Signatures in Recurrent Pregnancy Loss.

Qing Sha, Qiaoni Yu, Kaixing Chen, Junyu Wang, Feiyang Wang, Chen Jiang, Yuanzhe Li, Meifang Tang, Yanbing Hou, Ke Liu and 9 more

Abstract read
In one paragraph

Article in Genomics, proteomics & bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Insights into the maternal-fetal interface from spatial multi-omics.Frontiers in cell and developmental biology · 2026
    Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Qing ShaDepartment of Oncology, The First Affiliated Hospital of USTC, State Kye Laboratory of Eye Health, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230021, China.ORCID 0000-0002-8604-1975
Qiaoni YuDepartment of Oncology, The First Affiliated Hospital of USTC, State Kye Laboratory of Eye Health, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230021, China.ORCID 0000-0003-3272-7119
Kaixing ChenDepartment of Oncology, The First Affiliated Hospital of USTC, State Kye Laboratory of Eye Health, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230021, China.ORCID 0009-0000-8485-1432
Junyu WangDepartment of Oncology, The First Affiliated Hospital of USTC, State Kye Laboratory of Eye Health, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230021, China.ORCID 0009-0000-0621-3435
Feiyang WangState Key Laboratory of Stem Cell and Reproductive Biology, Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.ORCID 0000-0002-7866-5497
Chen JiangDepartment of Oncology, The First Affiliated Hospital of USTC, State Kye Laboratory of Eye Health, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230021, China.ORCID 0000-0002-1415-185X
Yuanzhe LiDepartment of Oncology, The First Affiliated Hospital of USTC, State Kye Laboratory of Eye Health, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230021, China.ORCID 0009-0002-1474-2809
Meifang TangDepartment of Oncology, The First Affiliated Hospital of USTC, State Kye Laboratory of Eye Health, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230021, China.ORCID 0009-0002-9780-7232
Yanbing HouDepartment of Oncology, The First Affiliated Hospital of USTC, State Kye Laboratory of Eye Health, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230021, China.ORCID 0009-0006-6028-7578
Ke LiuDepartment of Oncology, The First Affiliated Hospital of USTC, State Kye Laboratory of Eye Health, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230021, China.ORCID 0000-0001-9754-1492
Kun ChenDepartment of Oncology, The First Affiliated Hospital of USTC, State Kye Laboratory of Eye Health, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230021, China.ORCID 0009-0007-0147-651X
Zongcheng YangDepartment of Oncology, The First Affiliated Hospital of USTC, State Kye Laboratory of Eye Health, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230021, China.ORCID 0000-0001-8272-3728
Shouzhen LiDepartment of Oncology, The First Affiliated Hospital of USTC, State Kye Laboratory of Eye Health, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230021, China.ORCID 0000-0002-3780-5190
Jingwen FangDepartment of Oncology, The First Affiliated Hospital of USTC, State Kye Laboratory of Eye Health, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230021, China.ORCID 0000-0001-7906-8152
Sihui LuoDepartment of Endocrinology, Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Clinical Research Hospital of Chinese Academy of Sciences (Hefei), University of Science and Technology of China, Hefei 230001, China.ORCID 0000-0001-8503-0310
Xueying ZhengDepartment of Endocrinology, Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Clinical Research Hospital of Chinese Academy of Sciences (Hefei), University of Science and Technology of China, Hefei 230001, China.ORCID 0000-0001-8395-9476
Jianping WengDepartment of Endocrinology, Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, Clinical Research Hospital of Chinese Academy of Sciences (Hefei), University of Science and Technology of China, Hefei 230001, China.ORCID 0000-0002-7889-1697
Kun QuDepartment of Oncology, The First Affiliated Hospital of USTC, State Kye Laboratory of Eye Health, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230021, China.ORCID 0000-0002-5555-8437
Chuang GuoDepartment of Oncology, The First Affiliated Hospital of USTC, State Kye Laboratory of Eye Health, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230021, China.ORCID 0000-0002-3912-0793

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human decidua establishes immune tolerance at the maternal-fetal interface and is essential for successful embryo implantation and development. Here, we conducted a spatial transcriptomic analysis of human decidua from early pregnancies in both healthy donors and patients with recurrent pregnancy loss (RPL). Our analysis revealed two distinct spatial domains, named implantation zone (IZ) and glandular-secretory zone (GZ), corresponding to the layers of decidua compacta and spongiosa, respectively. The decidual natural killer cell subset (dNK1) and the decidual macrophage subset (dM2), both associated with growth promotion and immune regulation, were predominantly localized in the healthy IZ but were significantly reduced in RPL patients. In contrast, cytotoxic CD8+ T cells, sparsely distributed in the healthy decidual IZ and GZ domains, were elevated in both domains under RPL conditions. Spatial cell-cell interaction analysis indicated a broad exhibition but a marked downregulation of immunoregulatory interactions in the IZ of RPL patients. Through integrated single-cell chromatin accessibility and transcription factor occupancy analyses, we identified FOSL2 as a pivotal regulator orchestrating the spatial transformation of dNK1 cells. Decreased FOSL2 expression correlated with compromised IL-15-induced dNK1 cell transformation and diminished immunoregulatory capabilities. Our findings delineate the intricate spatial and regulatory architecture of immune tolerance within the human decidua, providing new insights into immune tolerance dysregulation in RPL.

Indexed as

Abortion, HabitualDeciduaTranscriptomeAdultFemaleHumansKiller Cells, NaturalPregnancySpatial TranscriptomicsDecidual natural killer celleEarly pregnancyImmune tolerancSpatial transcriptomic analysisTranscriptional regulation

Identifiers

PMID41031483
PMCPMC13242933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.